Noble buys Spring Valley; Which CRO will go public next?;

> Maryland's Noble Life Sciences has acquired rival CRO Spring Valley Laboratories for an undisclosed sum. More

> Following big IPOs from the likes of INC Research ($INCR), PRA ($PRAH) and Catalent ($CTLT), Outsourcing-Pharma takes a look at who might be next. Story

> Contract drug developer Vetter has expanded its presence in Chicago. More

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.